Skip to main content
Log in

The Role of the Pathologist in the Diagnosis and Treatment of Dysplasia in Inflammatory Bowel Disease

  • SSAT/ASCRS Joint Symposium
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Triantafillidis J, Nasioulas G, Kosmidi P.Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies. Anticancer Res 2009; 29: 2727-2738

    PubMed  Google Scholar 

  2. Lucas M. Inflammatory Bowel Disease as a Risk Factor for Colorectal Cancer. Dig Dis. 2010:619-624.

  3. Thomas T, Abrams KA, Robinson RJ et al. Meta-analysis: Cancer risk of low grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007;25:657-668.

    Article  CAS  PubMed  Google Scholar 

  4. Odze R, Goldblum J, Noffsinger A et al. Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol 2002;379-386

  5. Odze R, Tomaszewski J, Feldman M et al. Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology. Oncol Rep 2006;16:1123-1129.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariana Berho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berho, M., Allende, D. The Role of the Pathologist in the Diagnosis and Treatment of Dysplasia in Inflammatory Bowel Disease. J Gastrointest Surg 18, 1231–1233 (2014). https://doi.org/10.1007/s11605-014-2505-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-014-2505-5

Keywords

Navigation